Literature DB >> 10861425

Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.

J Lüttges1, A Diederichs, M A Menke, I Vogel, B Kremer, G Klöppel.   

Abstract

BACKGROUND: Chronic pancreatitis (CP) is considered to be a risk factor for the development of pancreatic carcinoma. The detection of K-ras mutations in the duodenal or pancreatic juice has been held to be a reliable tool for its early diagnosis. However, K-ras mutations also occur in hyperplastic ductal epithelium, making it difficult to interpret their role in pancreatic carcinogenesis.
METHODS: The study included 30 resection specimens, 15 from patients with alcoholic CP, and 15 from patients with idiopathic CP. The mean duration of disease was 6.8 years. A total of 429 ductal lesions were classified according to the World Health Organization classification (1996) and microdissected. K-ras analysis was performed by means of polymerase chain reaction (45 cycles), constant denaturing gel electrophoresis, and sequencing. Immunostaining was performed with antibodies against p53, Ki-S5, carcinoembryonic antigen, and two types of mucins.
RESULTS: The 30 specimens demonstrated all types of ductal lesions. Severe cellular atypia was not observed. A total of 429 ductal lesions were analyzed. Approximately 4.4% of the lesions (19 of 429) from 27% of the patients (8 of 30) showed K-ras mutations, but they were unrelated to the duration or type of CP. Immunostaining for mutated p53 protein always was negative. Increased proliferative activity was noted only in patients with papillary hyperplasia. No patient developed pancreatic carcinoma within a follow-up period of at least 3 years.
CONCLUSIONS: Ductal lesions in patients with CP exhibit K-ras mutations without additional indications of neoplastic transformation such as severe dysplasia or mutated p53 protein. Therefore, for diagnostic and therapeutic purposes, the detection of K-ras mutations should be supplemented by the demonstration of additional genetic alterations or clinical signs of malignancy. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861425     DOI: 10.1002/1097-0142(20000601)88:11<2495::aid-cncr10>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

2.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy.

Authors:  Alexander W Jahng; Sonya Reicher; David Chung; Donna Varela; Rahul Chhablani; Anil Dev; Binh Pham; Jose Nieto; Rose J Venegas; Samuel W French; Bruce E Stabile; Viktor E Eysselein
Journal:  World J Gastrointest Endosc       Date:  2010-11-16

Review 4.  Early detection and prevention of pancreatic cancer: is it really possible today?

Authors:  Marco Del Chiaro; Ralf Segersvärd; Matthias Lohr; Caroline Verbeke
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  K-ras and Dpc4 mutations in chronic pancreatitis: case series.

Authors:  Marijana Popović Hadzija; Marina Korolija; Jasminka Jakić Razumović; Pajica Pavković; Mirko Hadzija; Sanja Kapitanović
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

6.  [Indications for pancreatic biopsy. Uncommon, but increasingly more important].

Authors:  J-M Löhr; G Klöppel
Journal:  Pathologe       Date:  2005-02       Impact factor: 1.011

7.  K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Shin-Ichirou Horiguchi; Yukiko Hayashi; Xiaoqing Yun; Toshikazu Yamaguchi; Koji Tsuruta; Tsuneo Sasaki
Journal:  J Gastroenterol       Date:  2010-02-16       Impact factor: 7.527

Review 8.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

Review 9.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

10.  Ras activity levels control the development of pancreatic diseases.

Authors:  Baoan Ji; Lilian Tsou; Huamin Wang; Sebastian Gaiser; David Z Chang; Jaroslaw Daniluk; Yan Bi; Tobias Grote; Daniel S Longnecker; Craig D Logsdon
Journal:  Gastroenterology       Date:  2009-06-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.